Apyx Medical (NASDAQ:APYX) Posts Earnings Results, Beats Estimates By $0.05 EPS
Apyx Medical (NASDAQ:APYX) released its quarterly earnings data on Monday. The company reported ($0.13) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.18) by $0.05, Briefing.com reports. Apyx Medical had a net margin of 255.57% and a negative return on equity of 14.88%. The company had revenue of $7.58 million during the quarter, compared to analyst estimates of $6.78 million. Apyx Medical’s revenue for the quarter was up 106.3% on a year-over-year basis.
Shares of APYX stock traded up $0.78 during mid-day trading on Tuesday, hitting $8.00. 4,900 shares of the stock traded hands, compared to its average volume of 93,982. The stock has a market cap of $237.79 million, a P/E ratio of -24.90 and a beta of 0.09. The stock’s fifty day moving average is $6.70 and its two-hundred day moving average is $6.79. Apyx Medical has a 52-week low of $3.55 and a 52-week high of $8.89. The company has a debt-to-equity ratio of 0.01, a current ratio of 10.38 and a quick ratio of 9.57.
A number of analysts recently weighed in on APYX shares. ValuEngine raised shares of Apyx Medical from a “buy” rating to a “strong-buy” rating in a research note on Friday. Zacks Investment Research lowered shares of Apyx Medical from a “buy” rating to a “hold” rating in a research note on Monday, October 21st. Finally, Piper Jaffray Companies upped their price objective on shares of Apyx Medical to $10.00 and gave the stock an “overweight” rating in a research note on Monday. One equities research analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $8.69.
Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue.
Featured Article: What are the Different Types of Leveraged Buyouts?
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.